The v-SNARE Vti1a Inhibitors represent a distinctive class of chemical compounds designed to modulate cellular processes by targeting the vesicle-associated membrane protein (VAMP) known as Vti1a. V-SNAREs, or vesicle-soluble N-ethylmaleimide-sensitive factor attachment protein receptors, play a crucial role in intracellular membrane fusion events within eukaryotic cells. Vti1a, specifically, is a member of the V-SNARE family and is predominantly found in the membranes of vesicles involved in the transport of cargo within the endomembrane system. The inhibitors designed for Vti1a exert their effects by interfering with the normal functioning of this v-SNARE, thereby modulating intracellular trafficking and vesicle fusion events.
v-SNARE Vti1a Inhibitors are meticulously designed compounds that interact with the Vti1a protein to impede its engagement with other essential components of the vesicle fusion machinery. These inhibitors often exhibit a high degree of specificity, selectively targeting Vti1a without significantly affecting other v-SNAREs or related proteins. The rational design of these inhibitors involves a comprehensive understanding of the molecular interactions involved in vesicle fusion, allowing researchers to develop compounds that precisely interfere with the Vti1a-mediated fusion events. By doing so, these inhibitors provide valuable tools for probing and elucidating the intricate mechanisms governing intracellular transport, contributing to a more nuanced understanding of cellular processes. The ongoing research in this area aims to refine the design and optimize the efficacy of v-SNARE Vti1a Inhibitors, shedding light on their potential applications in basic research and further advancing our understanding of cellular dynamics.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $30.00 $52.00 $122.00 $367.00 | 25 | |
Disrupts the Golgi apparatus, indirectly affecting vesicular transport involving VTI1A. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $152.00 $515.00 | ||
Ionophore that disrupts Golgi function, thereby potentially affecting VTI1A-related trafficking. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $58.00 $83.00 $140.00 $242.00 | 38 | |
Destabilizes microtubules, which can disrupt vesicular transport and VTI1A function. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $87.00 | 44 | |
Inhibits dynamin, which is crucial for vesicle scission, indirectly affecting VTI1A's role. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $145.00 $442.00 | 64 | |
Inhibits actin polymerization, potentially impacting VTI1A-related vesicle movement. | ||||||
Golgicide A | 1005036-73-6 | sc-215103 sc-215103A | 5 mg 25 mg | $187.00 $670.00 | 11 | |
Specifically targets the Golgi apparatus, indirectly affecting VTI1A-mediated transport. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $169.00 $299.00 | 66 | |
Inhibits N-linked glycosylation, affecting vesicular transport and indirectly VTI1A. | ||||||
Colchicine | 64-86-8 | sc-203005 sc-203005A sc-203005B sc-203005C sc-203005D sc-203005E | 1 g 5 g 50 g 100 g 500 g 1 kg | $98.00 $315.00 $2244.00 $4396.00 $17850.00 $34068.00 | 3 | |
Alkaloid that disrupts microtubules, which may affect VTI1A-related vesicular transport. | ||||||
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $260.00 $799.00 | 36 | |
Disrupts microfilaments and can indirectly affect VTI1A-mediated vesicle traffic. | ||||||
Jasplakinolide | 102396-24-7 | sc-202191 sc-202191A | 50 µg 100 µg | $180.00 $299.00 | 59 | |
Stabilizes actin filaments, potentially disrupting processes that involve VTI1A. | ||||||